Reduced risk for pre-eclampsia among women who have aborted



Santaris Pharma announced today that SPC3042, a RNA-based antisense oligonucleotide developed using the company’s proprietary Locked Nucleic Acid (LNA) technology, potently blocks survivin, a key survival protein in cancer cells, in both in vitro and in vivo models of prostate cancer. Importantly, SPC3042 works synergistically with the anticancer drug paclitaxel (Taxol) in both model systems.

Full Post: Santaris Pharma releases positive data on LNA-based survivin inhibitor

Women who have had two or more induced abortions have a reduced risk of pre-eclampsia by 60%.

It is not currently understood to what degree physical activity during pregnancy protects against pre-eclampsia, compared to previous studies. This is shown in two new studies from the Norwegian Institute of Public Health (NIPH) that use data from the Norwegian Mother and Child Cohort Study (MoBa).

The new results from MoBa were presented on Friday 7th November at 21st Norwegian Perinatal Days, a conference organised jointly with the 2008 International Stillbirth Conference. The NIPH chaired the conference and many researchers from the NIPH presented research about stillbirth and findings from the MoBa.

Reduced risk for pre-eclampsia among women who have aborted

One study shows that women who have had two or more induced abortions reduced their risk for pre-eclampsia by 60 percent. That is, they are as well protected against pre-eclampsia as women who have previously given birth to a child. Women who have had one termination previously, have an approximately 16 % reduced risk for pre-eclampsia compared with women who have never had an abortion. There was no protective effect linked to having had a miscarriage previously.

These results are from a new study in MoBa, where the link between previously performed abortions, miscarriages and pre-eclampsia were studied. Information from 20 846 women was studied. All the women were first-time mothers, and some had previously had miscarriages or abortions.

The results indicate that every normal pregnancy, even if it ends before birth, to some degree will protect against pre-eclampsia in a later pregnancy, almost like a vaccination. The mechanisms for this effect are currently unknown, and more research is necessary. Miscarriages do not appear to protect against pre-eclampsia. This could be because pregnancies that end in miscarriage may have deficiencies which mean they cannot continue development but are rejected by the body. These deficiencies can be caused by many different conditions, amongst others problems in placenta formation. Perhaps miscarriage and pre-eclampsia are two related issues?

Found less protection from exercise than previous studies

The second study calculated the risk for pre-eclampsia if the pregnant woman was physically active during pregnancy. Information from 59 573 women in MoBa was studied. 1 in 4 reported that they were not physically active, whilst just under 1 in 10 women (7 percent) reported that they had taken part in more than 25 episodes of physical activity every month in the beginning of pregnancy.

By comparing these two groups, it was found that women who exercised had a 20 percent lower risk for pre-eclampsia. This was particularly relevant for women with BMI (Body Mass Index) under 25. Among women with BMI over 30, this study does not show any protection against pre-eclampsia despite physical activity.

Previous studies have shown significant exercise protection - from a 30 - 80 percent lower risk for pre-eclampsia among physically active pregnant women. This also applied to women with a BMI over 30.

The new study from MoBa emphasises that more research is needed before a conclusion on the link between physical activity in pregnancy and pre-eclampsia can be drawn.

In both studies, a range of factors have been taken into account that may affect results, e.g. smoking, age, mother’s weight, education, infertility treatment, time between abortion(s) and next birth and change of partner.

What is pre-eclampsia?

Pre-eclampsia is a complication that affects 3-5 % of all pregnant women. The risk for pre-eclampsia is greatest for first-time mothers. For women who have previously given birth to a child the risk is approximately halved. It is unknown why previous childbirth protects against pre-eclampsia in subsequent pregnancies.

Pre-eclampsia appears in the latter half of pregnancy, and is recognised by high blood pressure and protein in the urine in the mother. In some cases, the mother can be unaffected by the condition, but in severe cases, pre-eclampsia becomes life-threatening for mother and baby, with organ failure and risk of convulsions in the mother. The child risks poor growth and development because of insufficient placental function. The only treatment is delivery of the baby and placenta. Pre-eclampsia is therefore an important cause of premature birth.

Placenta vital for normal development

The causes of pre-eclampsia are unknown, but involve the placenta. The placenta is vital for a normal development of the pregnancy. Problems in the formation or function of the placenta are thought to be an important mechanism in the development of pre-eclampsia. It is unknown why this happens.

http://www.fhi.no/english

Link




Repeated miscarriages and hormone treatment for infertility give an increased risk of pre-eclampsia among pregnant women. This comes from a new study from the Norwegian Institute of Public Health. More than 20 000 first-time mothers from the Norwegian Mother and Child Cohort Study (MoBa) were included in the study. Normal risk First-time mothers

Full Post: Repeated miscarriages and hormone treatment for infertility increase pre-eclampsia risk



New Australian research has found that even minor, everyday stress during pregnancy possibly affects a developing foetus. Researchers from the Telethon Institute for Child Health Research in Western Australia say stress has an affect on the brain of the growing foetus and can cause problem behaviour by the time the child reaches pre-school age. According

Full Post: Avoid stress and exercise lots during pregnancy



Women who are exposed to hairspray in the workplace during pregnancy have more than double the risk of having a son with the genital birth defect hypospadias, according to a new study published today in the journal Environmental Health Perspectives. The study is the first to show a significant link between hairspray and hypospadias, one

Full Post: Significant link between hairspray and genital birth defect hypospadias



Socially disadvantaged mothers who receive home visits from trained community visitors are less likely to deliver low birth weight babies than other mothers in similar circumstances, a new study finds. Moreover, the earlier that visits occur in a women’s pregnancy, the greater the reduction. These results held true even after researchers adjusted for factors such

Full Post: Home visits lower likelihood of low birth weight babies



Women who smoke during pregnancy risk delivering aggressive kids according to a new Canada-Netherlands study published in the journal Development and Psychopathology. While previous studies have shown that smoking during gestation causes low birth weight, this research shows mothers who light up during pregnancy can predispose their offspring to an additional risk: violent behaviour. What’s

Full Post: Women who smoke during pregnancy risk having aggressive kids